CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-10 | McBride John S. Director | Grant or award · Restricted Stock Units | +3,430 | 3,430 | ||
| 2025-01-10 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2025-01-10 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Restricted Stock Units | +66,500 | 66,500 | ||
| 2025-01-10 | Katkin Keith Director | Grant or award · Stock Option (right to buy) | +77,175 | 77,175 | ||
| 2025-01-10 | Katkin Keith Director | Grant or award · Restricted Stock Units | +8,575 | 8,575 | ||
| 2025-01-10 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +150,500 | 150,500 | ||
| 2025-01-10 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Restricted Stock Units | +64,500 | 64,500 | ||
| 2025-01-10 | Robinson James A. Jr. Director | Grant or award · Restricted Stock Units | +3,430 | 3,430 | ||
| 2025-01-10 | Little Paul Sean Chief Financial Officer | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2025-01-10 | Little Paul Sean Chief Financial Officer | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2025-01-10 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +243,000 | 243,000 | ||
| 2025-01-10 | Perrin Steven President | Grant or award · Restricted Stock Units | +27,000 | 27,000 | ||
| 2025-01-10 | Lee June Director | Grant or award · Stock Option (right to buy) | +30,870 | 30,870 | ||
| 2025-01-10 | Lee June Director | Grant or award · Restricted Stock Units | +3,430 | 3,430 | ||
| 2025-01-10 | Kirk Allan Director | Grant or award · Stock Option (right to buy) | +30,870 | 30,870 | ||
| 2025-01-10 | Kirk Allan Director | Grant or award · Restricted Stock Units | +3,430 | 3,430 | ||
| 2024-11-21 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +474,350 | 474,350 | ||
| 2024-11-21 | Little Paul Sean Chief Financial Officer | Grant or award · Stock Option (right to buy) | +525,032 | 525,032 | ||
| 2024-11-21 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +840,438 | 840,438 | ||
| 2024-11-21 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,015,743 | 1,015,743 |
Page 2 of 15 · 300 trades